Given the importance of regulating PRR-initiated outcomes in intestinal immune homeostasis and the dysregulation in PRR pathway outcomes that can be observed in IBD1, we questioned whether the rs3764147 genotype in human LACC1 modulates PRR-initiated outcomes in human MDMs. This evidence concerns the gene LACC1 and inflammatory bowel disease 1.